Literature DB >> 2569483

Familial bone marrow monosomy 7. Evidence that the predisposing locus is not on the long arm of chromosome 7.

K M Shannon1, A G Turhan, S S Chang, A M Bowcock, P C Rogers, W L Carroll, M J Cowan, B E Glader, C J Eaves, A C Eaves.   

Abstract

Loss of expression of a tumor-suppressing gene is an attractive model to explain the cytogenetic and epidemiologic features of cases of myelodysplasia and acute myelogenous leukemia (AML) associated with bone marrow monosomy 7 or partial deletion of the long arm (7q-). We used probes from within the breakpoint region on 7q-chromosomes (7q22-34) that detect restriction fragment length polymorphisms (RFLPs) to investigate three families in which two siblings developed myelodysplasia with monosomy 7. In the first family, probes from the proximal part of this region identified DNA derived from the same maternal chromosome in both leukemias. The RFLPs in these siblings diverged at the more distal J3.11 marker due to a mitotic recombination in one patient, a result that suggested a critical region on 7q proximal to probe J3.11. Detailed RFLP mapping of the implicated region was then performed in two additional unrelated pairs of affected siblings. In these families, DNA derived from different parental chromosome 7s was retained in the leukemic bone marrows of the siblings. We conclude that the familial predisposition to myelodysplasia is not located within a consistently deleted segment on the long arm of chromosome 7. These data provide evidence implicating multiple genetic events in the pathogenesis of myelodysplasia seen in association with bone marrow monosomy 7 or 7q-.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2569483      PMCID: PMC329745          DOI: 10.1172/JCI114262

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  40 in total

1.  A candidate for the cystic fibrosis locus isolated by selection for methylation-free islands.

Authors:  X Estivill; M Farrall; P J Scambler; G M Bell; K M Hawley; N J Lench; G P Bates; H C Kruyer; P A Frederick; P Stanier
Journal:  Nature       Date:  1987 Apr 30-May 6       Impact factor: 49.962

2.  Localization of the gene for familial adenomatous polyposis on chromosome 5.

Authors:  W F Bodmer; C J Bailey; J Bodmer; H J Bussey; A Ellis; P Gorman; F C Lucibello; V A Murday; S H Rider; P Scambler
Journal:  Nature       Date:  1987 Aug 13-19       Impact factor: 49.962

3.  Deletion of genes on chromosome 1 in endocrine neoplasia.

Authors:  C G Mathew; B A Smith; K Thorpe; Z Wong; N J Royle; A J Jeffreys; B A Ponder
Journal:  Nature       Date:  1987 Aug 6-12       Impact factor: 49.962

4.  Structural evidence for the authenticity of the human retinoblastoma gene.

Authors:  Y K Fung; A L Murphree; A T'Ang; J Qian; S H Hinrichs; W F Benedict
Journal:  Science       Date:  1987-06-26       Impact factor: 47.728

5.  Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkage.

Authors:  N E Simpson; K K Kidd; P J Goodfellow; H McDermid; S Myers; J R Kidd; C E Jackson; A M Duncan; L A Farrer; K Brasch
Journal:  Nature       Date:  1987 Aug 6-12       Impact factor: 49.962

6.  Chromosome 5 allele loss in human colorectal carcinomas.

Authors:  E Solomon; R Voss; V Hall; W F Bodmer; J R Jass; A J Jeffreys; F C Lucibello; I Patel; S H Rider
Journal:  Nature       Date:  1987 Aug 13-19       Impact factor: 49.962

7.  A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10.

Authors:  C G Mathew; K S Chin; D F Easton; K Thorpe; C Carter; G I Liou; S L Fong; C D Bridges; H Haak; A C Kruseman
Journal:  Nature       Date:  1987 Aug 6-12       Impact factor: 49.962

8.  Simple monosomy 7 and myelodysplastic syndrome in thirteen patients without previous cytostatic treatment.

Authors:  J J Michiels; H Mallios-Zorbala; M E Prins; K Hählen; A Hagemeijer
Journal:  Br J Haematol       Date:  1986-11       Impact factor: 6.998

9.  Human retinoblastoma susceptibility gene: cloning, identification, and sequence.

Authors:  W H Lee; R Bookstein; F Hong; L J Young; J Y Shew; E Y Lee
Journal:  Science       Date:  1987-03-13       Impact factor: 47.728

10.  Localization of cystic fibrosis locus to human chromosome 7cen-q22.

Authors:  B J Wainwright; P J Scambler; J Schmidtke; E A Watson; H Y Law; M Farrall; H J Cooke; H Eiberg; R Williamson
Journal:  Nature       Date:  1985 Nov 28-Dec 4       Impact factor: 49.962

View more
  8 in total

1.  Germ-line GATA2 p.THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival.

Authors:  Csaba Bödör; Aline Renneville; Matthew Smith; Aurélie Charazac; Sameena Iqbal; Pascaline Etancelin; Jamie Cavenagh; Michael J Barnett; Karolina Kramarzová; Biju Krishnan; András Matolcsy; Claude Preudhomme; Jude Fitzgibbon; Carolyn Owen
Journal:  Haematologica       Date:  2012-01-22       Impact factor: 9.941

2.  The rate of telomere sequence loss in human leukocytes varies with age.

Authors:  R W Frenck; E H Blackburn; K M Shannon
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

Review 3.  Familial myelodysplastic syndromes: a review of the literature.

Authors:  Elena Liew; Carolyn Owen
Journal:  Haematologica       Date:  2011-05-23       Impact factor: 9.941

4.  Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms.

Authors:  Bianca Tesi; Josef Davidsson; Matthias Voss; Elisa Rahikkala; Tim D Holmes; Samuel C C Chiang; Jonna Komulainen-Ebrahim; Sorina Gorcenco; Alexandra Rundberg Nilsson; Tim Ripperger; Hannaleena Kokkonen; David Bryder; Thoas Fioretos; Jan-Inge Henter; Merja Möttönen; Riitta Niinimäki; Lars Nilsson; Cornelis Jan Pronk; Andreas Puschmann; Hong Qian; Johanna Uusimaa; Jukka Moilanen; Ulf Tedgård; Jörg Cammenga; Yenan T Bryceson
Journal:  Blood       Date:  2017-02-15       Impact factor: 22.113

5.  Germline SAMD9 mutation in siblings with monosomy 7 and myelodysplastic syndrome.

Authors:  J R Schwartz; S Wang; J Ma; T Lamprecht; M Walsh; G Song; S C Raimondi; G Wu; M F Walsh; R B McGee; C Kesserwan; K E Nichols; B E Cauff; R C Ribeiro; M Wlodarski; J M Klco
Journal:  Leukemia       Date:  2017-05-10       Impact factor: 11.528

Review 6.  SAMD9 and SAMD9L in inherited predisposition to ataxia, pancytopenia, and myeloid malignancies.

Authors:  Josef Davidsson; Andreas Puschmann; Ulf Tedgård; David Bryder; Lars Nilsson; Jörg Cammenga
Journal:  Leukemia       Date:  2018-02-25       Impact factor: 11.528

7.  Germline SAMD9 and SAMD9L mutations are associated with extensive genetic evolution and diverse hematologic outcomes.

Authors:  Jasmine C Wong; Victoria Bryant; Tamara Lamprecht; Jing Ma; Michael Walsh; Jason Schwartz; Maria Del Pilar Alzamora; Charles G Mullighan; Mignon L Loh; Raul Ribeiro; James R Downing; William L Carroll; Jeffrey Davis; Stuart Gold; Paul C Rogers; Sara Israels; Rochelle Yanofsky; Kevin Shannon; Jeffery M Klco
Journal:  JCI Insight       Date:  2018-07-26

8.  Leukoencephalopathia, demyelinating peripheral neuropathy and dural ectasia explained by a not formerly described de novo mutation in the SAMD9L gene, ends 27 years of investigations - a case report.

Authors:  Sofia Thunström; Markus Axelsson
Journal:  BMC Neurol       Date:  2019-05-03       Impact factor: 2.474

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.